Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer

5 Apr 2022

Abstract excerpt

Abstract Objective N 6 -methyladenosine (m 6 A) mRNA modification triggers malignant behaviors of tumor cells and thereby drives malignant progression in gastric cancer (GC). However, data regarding the prognostic values of m 6 A RNA methylation-related long non-coding RNAs (lncRNAs) in GC are very limited in the literature. We aimed to investigate the prognostic potential of m 6 A-related lncRNAs in predicting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35382776
DOI: 10.1186/s12885-021-09062-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancerPMID 35382776Read ↗

Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAsSemantic proximity Read ↗

A m6A-related lncRNA Signature as a Novel Prognostic Factor for Gastric CancerSemantic proximity Read ↗

N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patientsSemantic proximity Read ↗

Analysis and Prognosis of Tumor Immune Infiltrates and Immune Microenvironment of m6A-Related LncRNAs in Patients with Gastric CancerSemantic proximity Read ↗

Comprehensive Analysis of Tumor Immune Microenvironment and Prognosis of m6A-Related lncRNAs in Gastric CancerSemantic proximity Read ↗

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancerSemantic proximity Read ↗

Novel M7G-Related lncRNA Signature for Predicting Overall Survival in Patients with Gastric CancerSemantic proximity Read ↗

N6-Methylandenosine-related lncRNAs as potential biomarkers for predicting prognosis and the immunotherapy response in pancreatic cancerSemantic proximity Read ↗

N6-methyladenosine demethylase FTO serves as an indicator for predicting prognosis and immunotherapy response in individuals with gastric cancerSemantic proximity Read ↗

Identification of a novel pyroptosis related long noncoding RNA subtypes, development of a prognostic model and characteristics of the tumor microenvironment in gastric cancerSemantic proximity Read ↗

Prognostic signature and immune landscape of 5-methylcytosine-related long non-coding RNAs in gastric cancerSemantic proximity Read ↗

Identification of Five m6A-Relevant mRNAs Signature and Risk Score for The Prognostication of Gastric CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.